MedTrace Logo

Gastrointestinal Tolerance and Safety of an Infant Formula Containing Prebiotics, Probiotics and Postbiotics.

NCT04745455 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2022-01-25

No results posted yet for this study

Summary

A study to investigate the gastrointestinal tolerance and safety of a new formula containing prebiotics, probiotics and postbiotics.

Conditions

  • Gastrointestinal Tolerance

Interventions

OTHER

Infant formula containing prebiotics, probiotics and postbiotics

Infant formula containing prebiotics, probiotics and postbiotics

Sponsors & Collaborators

  • Nutricia Research

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
14 Days
Max Age
84 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-22
Primary Completion
2021-07-12
Completion
2021-07-12

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04745455 on ClinicalTrials.gov